Efficacy and Tolerability of Lopinavir/Ritonavir- And Efavirenz-Based Initial Antiretroviral Therapy in HIV-1-Infected Patients in a Tertiary Care Hospital in Beijing, China
Frontiers in Pharmacology - Switzerland
doi 10.3389/fphar.2019.01472
Full Text
Open PDFAbstract
Available in full text
Categories
Date
December 12, 2019
Authors
Publisher
Frontiers Media SA